CivatlasThe Civilization Atlas

Company

Xaira Therapeutics

Latest funding:
$200M · Series A · Aug 2025
Show on map

Overview

Builds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation for patients.

Timeline

  1. series-a · $200M · led by ARCH Venture Partnersbloomberg.com ↗